{"version":"company-facts.v1","source":"https://secwatch.observer","generated_at":"2026-07-11T13:08:19.166687+00:00","company":{"ticker":"CERS","cik":1020214,"company_name":"CERUS CORP"},"pagination":{"limit":100,"returned":35,"next_cursor":null},"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer","counterparties":{"contract_counterparty":[{"display_name":"MidCap Financial Trust","detail":"credit_facility","count":3,"first_seen":"2023-04-05T23:59:59+00:00","last_seen":"2026-06-08T20:20:03+00:00","evidence_fact_ids":[82804,98519,166879]},{"display_name":"MidCap Funding IV Trust","detail":"credit_facility","count":2,"first_seen":"2023-04-05T23:59:59+00:00","last_seen":"2026-06-08T20:20:03+00:00","evidence_fact_ids":[98520,166880]}],"lender":[{"display_name":"MidCap Financial Trust","detail":"credit_facility","count":2,"first_seen":"2023-04-05T23:59:59+00:00","last_seen":"2026-06-08T20:20:03+00:00","evidence_fact_ids":[98522,166882]},{"display_name":"MidCap Funding IV Trust","detail":"revolving_credit","count":2,"first_seen":"2023-04-05T23:59:59+00:00","last_seen":"2026-06-08T20:20:03+00:00","evidence_fact_ids":[98523,166883]}]},"facts":[{"fact_type":"executive_change","fact_key":"51eb1064a9","cik":1020214,"ticker":"CERS","company_name":"CERUS CORP","filed_at":"2026-07-10T20:35:47+00:00","payload":{"action":"appointed","action_category":"role_change","departure_tone":"not_applicable","effective_date":"2026-07-01","interim":false,"role":"Executive Chairman","role_category":"chair","successor_name":null,"successor_named":false},"claim":"William Greenman was appointed as Executive Chairman at CERUS CORP.","evidence_excerpt":"William “Obi” Greenman, former President and Chief Executive Officer and Chairman of the Board of Directors (the “Board”) of Cerus Corporation (the “Company”), ceased serving as President and Chief Executive Officer and began serving as Executive Chairman of the Board effective July 1, 2026 (the “Effective Date”).","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001020214-26-000015","anchor_url":"https://secwatch.observer/filing/0001020214-26-000015#claim-51eb1064a9","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1020214/000102021426000015/0001020214-26-000015-index.htm"},{"fact_type":"debt_financing","fact_key":"cddbf78424812b9f3cc90768428f71296daaa3ae","cik":1020214,"ticker":"CERS","company_name":"CERUS CORP","filed_at":"2026-06-08T20:20:03+00:00","payload":{"counterparty":"MidCap Funding IV Trust","effective_date":"2026-06-05","event":"incurrence","instrument_type":"revolving_credit","interest_rate_text":"Term SOFR rate (subject to a floor of 1.00%) plus 3.70%","item_codes_triggered":["2.03"],"maturity_text":"June 1, 2031","principal_text":"up to $30.0 million"},"claim":"CERUS CORP incurred revolving credit of up to $30.0 million with MidCap Funding IV Trust at Term SOFR rate (subject to a floor of 1.00%) plus 3.70% maturing June 1, 2031.","evidence_excerpt":"The Revolving Loan Credit Agreement provides a secured revolving credit facility in an initial aggregate principal amount of up to $30.0 million.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-26-261794","anchor_url":"https://secwatch.observer/filing/0001193125-26-261794#claim-cddbf78424812b9f3cc90768428f71296daaa3ae","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1020214/000119312526261794/0001193125-26-261794-index.htm"},{"fact_type":"debt_financing","fact_key":"6100d472277ad328e62040d8ad44665007efcb33","cik":1020214,"ticker":"CERS","company_name":"CERUS CORP","filed_at":"2026-06-08T20:20:03+00:00","payload":{"counterparty":"MidCap Financial Trust","effective_date":"2026-06-05","event":"incurrence","instrument_type":"credit_facility","interest_rate_text":"Term SOFR rate (subject to a floor of 1.00%) plus 5.50%","item_codes_triggered":["2.03"],"maturity_text":null,"principal_text":"up to $65.0 million"},"claim":"CERUS CORP incurred credit facility of up to $65.0 million with MidCap Financial Trust at Term SOFR rate (subject to a floor of 1.00%) plus 5.50%.","evidence_excerpt":"The Term Loan Credit Agreement provides a secured term loan facility in an aggregate principal amount of up to $65.0 million.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-26-261794","anchor_url":"https://secwatch.observer/filing/0001193125-26-261794#claim-6100d472277ad328e62040d8ad44665007efcb33","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1020214/000119312526261794/0001193125-26-261794-index.htm"},{"fact_type":"material_agreement","fact_key":"6f0464a9894d8e133c5385c7e912c42bbf588205","cik":1020214,"ticker":"CERS","company_name":"CERUS CORP","filed_at":"2026-06-08T20:20:03+00:00","payload":{"action":"amendment","agreement_name":"Second Amended and Restated Credit, Security and Guaranty Agreement (Revolving Loan)","agreement_type":"credit_facility","counterparty":"MidCap Funding IV Trust, as agent and a lender","effective_date":"2026-06-05","item_codes_triggered":["1.01","1.02"],"value_text":"up to $30.0 million"},"claim":"CERUS CORP amended Second Amended and Restated Credit, Security and Guaranty Agreement (Revolving Loan) with MidCap Funding IV Trust, as agent and a lender valued at up to $30.0 million (effective 2026-06-05).","evidence_excerpt":"(ii) a Second Amended and Restated Credit, Security and Guaranty Agreement (Revolving Loan) (the “Revolving Loan Credit Agreement,” and together with the Term Loan Credit Agreement, the “Credit Agreements”), by and among the Company, the lenders party thereto from time to time and MidCap Funding IV Trust, as agent and a lender, which amended and restated the Company’s existing Amended and Restated Credit, Security and Guaranty Agreement (Revolving Loan), dated as of March 31, 2023, as amended","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-26-261794","anchor_url":"https://secwatch.observer/filing/0001193125-26-261794#claim-6f0464a9894d8e133c5385c7e912c42bbf588205","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1020214/000119312526261794/0001193125-26-261794-index.htm"},{"fact_type":"material_agreement","fact_key":"8acc37f7aefe31eab5cbbc05cc81d2873c4e3ce1","cik":1020214,"ticker":"CERS","company_name":"CERUS CORP","filed_at":"2026-06-08T20:20:03+00:00","payload":{"action":"amendment","agreement_name":"Second Amended and Restated Credit, Security and Guaranty Agreement (Term Loan)","agreement_type":"credit_facility","counterparty":"MidCap Financial Trust, as agent and a lender","effective_date":"2026-06-05","item_codes_triggered":["1.01","1.02"],"value_text":"up to $65.0 million"},"claim":"CERUS CORP amended Second Amended and Restated Credit, Security and Guaranty Agreement (Term Loan) with MidCap Financial Trust, as agent and a lender valued at up to $65.0 million (effective 2026-06-05).","evidence_excerpt":"On June 5, 2026, (the “Closing Date”), Cerus Corporation (the “Company”) entered into (i) a Second Amended and Restated Credit, Security and Guaranty Agreement (Term Loan) (the “Term Loan Credit Agreement”), by and among the Company, the lenders party thereto from time to time (the “Term Loan Lenders”) and MidCap Financial Trust, as agent and a lender, which amended and restated the Company’s existing Amended and Restated Credit, Security and Guaranty Agreement (Term Loan), dated as of March 31, 2023, as amended","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-26-261794","anchor_url":"https://secwatch.observer/filing/0001193125-26-261794#claim-8acc37f7aefe31eab5cbbc05cc81d2873c4e3ce1","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1020214/000119312526261794/0001193125-26-261794-index.htm"},{"fact_type":"shareholder_vote","fact_key":"b9462187d41134500b2ca5e90d1054867708986a","cik":1020214,"ticker":"CERS","company_name":"CERUS CORP","filed_at":"2026-06-03T20:17:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2026-06-02","outcome":"passed","proposal_text":"Ratification of selection of Ernst & Young LLP as independent registered public accounting firm for fiscal year ending December 31, 2026","proposal_type":"auditor_ratification","results":[{"broker_non_votes":null,"subject":null,"votes_abstain":"735,277","votes_against":"2,173,933","votes_for":"164,256,582","votes_withheld":null}]},"claim":"CERUS CORP shareholders approved Ratification of selection of Ernst & Young LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-06-02 meeting.","evidence_excerpt":"Proposal 4 The Company’s stockholders ratified the selection of Ernst & Young LLP as the independent registered public accounting firm for the Company for its fiscal year ending December 31, 2026. For Against Abstain 164,256,582 2,173,933 735,277","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0001193125-26-255488","anchor_url":"https://secwatch.observer/filing/0001193125-26-255488#claim-b9462187d41134500b2ca5e90d1054867708986a","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1020214/000119312526255488/0001193125-26-255488-index.htm"},{"fact_type":"shareholder_vote","fact_key":"788bcd631bae391bfdd0e22a5ddac79b8d16d4bb","cik":1020214,"ticker":"CERS","company_name":"CERUS CORP","filed_at":"2026-06-03T20:17:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2026-06-02","outcome":"passed","proposal_text":"Advisory vote on the compensation of named executive officers as disclosed in the Proxy Statement","proposal_type":"say_on_pay","results":[{"broker_non_votes":"34,678,292","subject":null,"votes_abstain":"629,704","votes_against":"10,952,287","votes_for":"120,905,509","votes_withheld":null}]},"claim":"CERUS CORP shareholders approved Advisory vote on the compensation of named executive officers as disclosed in the Proxy Statement at the 2026-06-02 meeting.","evidence_excerpt":"Proposal 3 The Company’s stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers as disclosed in the Proxy Statement. For Against Abstain Broker Non-Votes 120,905,509 10,952,287 629,704 34,678,292","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0001193125-26-255488","anchor_url":"https://secwatch.observer/filing/0001193125-26-255488#claim-788bcd631bae391bfdd0e22a5ddac79b8d16d4bb","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1020214/000119312526255488/0001193125-26-255488-index.htm"},{"fact_type":"shareholder_vote","fact_key":"2c629a826d9c3d7a4b95167e45996c8fa1971322","cik":1020214,"ticker":"CERS","company_name":"CERUS CORP","filed_at":"2026-06-03T20:17:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2026-06-02","outcome":"passed","proposal_text":"Approval of the Amendment and Restatement of the Company’s 2024 Equity Incentive Plan to, among other things, increase the aggregate number of shares of common stock available for issuance thereunder by 10,000,000 shares","proposal_type":"equity_plan","results":[{"broker_non_votes":"34,678,292","subject":null,"votes_abstain":"87,838","votes_against":"42,567,475","votes_for":"89,832,187","votes_withheld":null}]},"claim":"CERUS CORP shareholders approved Approval of the Amendment and Restatement of the Company’s 2024 Equity Incentive Plan to, among other things, increase the aggregate number of shares of common stock available for issuance thereunder by 10,000,000 shares at the 2026-06-02 meeting.","evidence_excerpt":"Proposal 2 The Company’s stockholders approved the amendment and restatement of the Company’s 2024 Equity Incentive Plan to, among other things, increase the aggregate number of shares of common stock available for issuance thereunder by 10,000,000 shares as described in the Proxy Statement. For Against Abstain Broker Non-Votes 89,832,187 42,567,475 87,838 34,678,292","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0001193125-26-255488","anchor_url":"https://secwatch.observer/filing/0001193125-26-255488#claim-2c629a826d9c3d7a4b95167e45996c8fa1971322","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1020214/000119312526255488/0001193125-26-255488-index.htm"},{"fact_type":"shareholder_vote","fact_key":"84616aa86ba555b559781cbda41c647b64578848","cik":1020214,"ticker":"CERS","company_name":"CERUS CORP","filed_at":"2026-06-03T20:17:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2026-06-02","outcome":"passed","proposal_text":"Election of Directors","proposal_type":"director_election","results":[{"broker_non_votes":"34,678,292","subject":"William M. Greenman","votes_abstain":null,"votes_against":null,"votes_for":"124,675,657","votes_withheld":"7,811,843"},{"broker_non_votes":"34,678,292","subject":"Ann Lucena","votes_abstain":null,"votes_against":null,"votes_for":"124,854,827","votes_withheld":"7,632,673"}]},"claim":"CERUS CORP shareholders approved Election of Directors at the 2026-06-02 meeting.","evidence_excerpt":"Proposal 1 The Company’s stockholders elected each of the two nominees named below to the Board of Directors to serve until the 2029 Annual Meeting of Stockholders or until his or her respective successor has been duly elected and qualified. Nominee For Withheld Broker Non-Votes William M. Greenman 124,675,657 7,811,843 34,678,292 Ann Lucena 124,854,827 7,632,673 34,678,292","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0001193125-26-255488","anchor_url":"https://secwatch.observer/filing/0001193125-26-255488#claim-84616aa86ba555b559781cbda41c647b64578848","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1020214/000119312526255488/0001193125-26-255488-index.htm"},{"fact_type":"earnings_release","fact_key":"46fb8aa09ed5b976353cd4e4015ff46de0aa53e8","cik":1020214,"ticker":"CERS","company_name":"CERUS CORP","filed_at":"2026-04-30T23:59:59+00:00","payload":{"eps_text":null,"guidance_signal":"raised","item_codes_triggered":["2.02"],"net_income_text":"$1.6 million, or $0.01 per basic and diluted share","period_text":"first quarter ended March 31, 2026","report_date":"2026-04-30","result_type":"reported_results","revenue_text":"$59.9 million"},"claim":"CERUS CORP reported first quarter ended March 31, 2026 results: revenue $59.9 million, net income $1.6 million, or $0.01 per basic and diluted share. Guidance raised.","evidence_excerpt":"reference in such filing. \n\n--- EX-99.1 (EX-99.1) ---\n\nEX-99.1 Exhibit 99.1 Cerus Corporation Announces First Quarter 2026 Financial Results First Quarter 2026 Total Revenue of $59.9 million, Up 23% Over Prior Year; First Quarter 2026 Product Revenue of $53.7 million, Up 24% Over Prior Year Raising Full Year Product Revenue Guidance Range to $227 million - $231","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-26-197129","anchor_url":"https://secwatch.observer/filing/0001193125-26-197129#claim-46fb8aa09ed5b976353cd4e4015ff46de0aa53e8","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1020214/000119312526197129/0001193125-26-197129-index.htm"},{"fact_type":"executive_change","fact_key":"86eeccd046","cik":1020214,"ticker":"CERS","company_name":"CERUS CORP","filed_at":"2025-06-23T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2025-06-20","interim":false,"role":"Chair of the Board","role_category":"chair","successor_name":null,"successor_named":false},"claim":"William M. Greenman was appointed as Chair of the Board at CERUS CORP.","evidence_excerpt":"on June 20, 2025, the Board appointed William M. Greenman, the Company’s President and Chief Executive Officer and a member of the class of directors whose terms of office expire at the Company’s 2026 annual meeting of stockholders, to serve as chair of the Board","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000950170-25-089029","anchor_url":"https://secwatch.observer/filing/0000950170-25-089029#claim-86eeccd046","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1020214/000095017025089029/0000950170-25-089029-index.htm"},{"fact_type":"executive_change","fact_key":"f0e2b97785","cik":1020214,"ticker":"CERS","company_name":"CERUS CORP","filed_at":"2025-06-23T23:59:59+00:00","payload":{"action":"retired","action_category":"departure","departure_tone":"routine","effective_date":"2025-06-16","interim":false,"role":"Chair of the Board","role_category":"chair","successor_name":"William M. Greenman","successor_named":true},"claim":"Daniel N. Swisher, Jr. retired as Chair of the Board at CERUS CORP.","evidence_excerpt":"On June 16, 2025, Daniel N. Swisher, Jr., chair of the board of directors (the “Board”) of Cerus Corporation (the “Company”), notified the Company of his intent to retire from the Board and all committees thereof on which he served, effective immediately.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000950170-25-089029","anchor_url":"https://secwatch.observer/filing/0000950170-25-089029#claim-f0e2b97785","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1020214/000095017025089029/0000950170-25-089029-index.htm"},{"fact_type":"executive_change","fact_key":"44ba44c02e","cik":1020214,"ticker":"CERS","company_name":"CERUS CORP","filed_at":"2025-02-06T23:59:59+00:00","payload":{"action":"not stand for re-election","action_category":"departure","departure_tone":"routine","effective_date":null,"interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Gail Schulze departed as Director at CERUS CORP.","evidence_excerpt":"On February 2, 2025, Gail Schulze, a member of the class of directors whose terms of office expire at the 2025 annual meeting of stockholders (the “2025 Annual Meeting”) of Cerus Corporation (the “Company”), informed the Company that she would not stand for re-election at the 2025 Annual Meeting.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000950170-25-015365","anchor_url":"https://secwatch.observer/filing/0000950170-25-015365#claim-44ba44c02e","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1020214/000095017025015365/0000950170-25-015365-index.htm"},{"fact_type":"executive_change","fact_key":"403f7d8250","cik":1020214,"ticker":"CERS","company_name":"CERUS CORP","filed_at":"2024-07-02T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-07-01","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Dean Gregory was appointed as Director at CERUS CORP.","evidence_excerpt":"the Board extended an offer to join the Board to Dean Gregory, and on July 1, 2024, Mr. Gregory accepted such offer to join the Board, effective July 1, 2024.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000950170-24-080426","anchor_url":"https://secwatch.observer/filing/0000950170-24-080426#claim-403f7d8250","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1020214/000095017024080426/0000950170-24-080426-index.htm"},{"fact_type":"earnings_release","fact_key":"98ceaded38b5e5d4b2c046211c7621d5b895b3a2","cik":1020214,"ticker":"CERS","company_name":"CERUS CORP","filed_at":"2024-05-02T23:59:59+00:00","payload":{"eps_text":null,"guidance_signal":"reaffirmed","item_codes_triggered":["2.02"],"net_income_text":null,"period_text":"first quarter ended March 31, 2024","report_date":"2024-05-02","result_type":"reported_results","revenue_text":null},"claim":"CERUS CORP updated its first quarter ended March 31, 2024 guidance (reaffirmed).","evidence_excerpt":"On May 2, 2024, Cerus Corporation (the “Company”) announced its financial results for its first quarter ended March 31, 2024.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0000950170-24-052053","anchor_url":"https://secwatch.observer/filing/0000950170-24-052053#claim-98ceaded38b5e5d4b2c046211c7621d5b895b3a2","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1020214/000095017024052053/0000950170-24-052053-index.htm"},{"fact_type":"earnings_release","fact_key":"5a80b20c60ea2af61c3ce874f506c2a98697b86d","cik":1020214,"ticker":"CERS","company_name":"CERUS CORP","filed_at":"2024-03-05T23:59:59+00:00","payload":{"eps_text":"$0.01 per basic and diluted share","guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":"Net loss attributable to Cerus Corporation for the fourth quarter of 2023 was $1.3 million","period_text":"Fourth Quarter 2023","report_date":"2024-03-05","result_type":"reported_results","revenue_text":"$53,342"},"claim":"CERUS CORP reported Fourth Quarter 2023 results: revenue $53,342, net income Net loss attributable to Cerus Corporation for the fourth quarter of 2023 was $1.3 million, EPS $0.01 per basic and diluted share.","evidence_excerpt":"Total Revenue $53,342 $51,321 $2,021 4% $186,797 $188,315 $(1,518) -1%","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0000950170-24-025891","anchor_url":"https://secwatch.observer/filing/0000950170-24-025891#claim-5a80b20c60ea2af61c3ce874f506c2a98697b86d","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1020214/000095017024025891/0000950170-24-025891-index.htm"},{"fact_type":"earnings_release","fact_key":"73259f6acee54e4d348c4821df748c96a9ae3d41","cik":1020214,"ticker":"CERS","company_name":"CERUS CORP","filed_at":"2024-03-05T23:59:59+00:00","payload":{"eps_text":null,"guidance_signal":"reaffirmed","item_codes_triggered":["2.02"],"net_income_text":null,"period_text":"Full-Year 2024","report_date":"2024-03-05","result_type":"guidance_update","revenue_text":"$172-175 Million"},"claim":"CERUS CORP reported Full-Year 2024 results: revenue $172-175 Million. Guidance reaffirmed.","evidence_excerpt":"The Company is reiterating its full-year 2024 annual product revenue guidance range of $172 million to $175 million.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0000950170-24-025891","anchor_url":"https://secwatch.observer/filing/0000950170-24-025891#claim-73259f6acee54e4d348c4821df748c96a9ae3d41","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1020214/000095017024025891/0000950170-24-025891-index.htm"},{"fact_type":"earnings_release","fact_key":"baf9b371b6cadfa1caf3374d0e435c498099708f","cik":1020214,"ticker":"CERS","company_name":"CERUS CORP","filed_at":"2024-03-05T23:59:59+00:00","payload":{"eps_text":"$0.01 per basic and diluted share","guidance_signal":"reaffirmed","item_codes_triggered":["2.02"],"net_income_text":"Net loss attributable to Cerus Corporation for the fourth quarter of 2023 was $1.3 million","period_text":"Fourth Quarter and Full-Year 2023","report_date":"2024-03-05","result_type":"reported_results","revenue_text":"$53,342"},"claim":"CERUS CORP reported Fourth Quarter and Full-Year 2023 results: revenue $53,342, net income Net loss attributable to Cerus Corporation for the fourth quarter of 2023 was $1.3 million, EPS $0.01 per basic and diluted share. Guidance reaffirmed.","evidence_excerpt":"% 2023 2022 $ % Product Revenue $46,768 $44,034 $2,734 6% $156,367 $162,048 $(5,681) -4% Government Contract Revenue 6,574 7,287 (713) -10% 30,430 26,267 4,163 16% Total Revenue $53,342 $51,321 $2,021 4% $186,797 $188,315 $(1,518) -1% • The Company is reiterating its full-year 2024 annual product revenue guidance range of $172 million to $175 million. Included in","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0000950170-24-025891","anchor_url":"https://secwatch.observer/filing/0000950170-24-025891#claim-baf9b371b6cadfa1caf3374d0e435c498099708f","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1020214/000095017024025891/0000950170-24-025891-index.htm"},{"fact_type":"governance_change","fact_key":"d011fdc10748f4b98e2327e3630754bcde739a0c","cik":1020214,"ticker":"CERS","company_name":"CERUS CORP","filed_at":"2024-01-05T23:59:59+00:00","payload":{"change_type":"bylaw_amendment","effective_date":"2024-01-04","item_codes_triggered":["5.03"],"summary_text":"The Board approved an amendment and restatement of the Company's Bylaws, including changes to stockholder meeting procedures, advance notice provisions, universal proxy rules, and exclusive forum provisions."},"claim":"CERUS CORP: The Board approved an amendment and restatement of the Company's Bylaws, including changes to stockholder meeting procedures, advance notice provisions, universal proxy rules, and exclusive forum provisions (effective 2024-01-04).","evidence_excerpt":"On January 4, 2024, the Board of Directors (the “Board”) of the Company approved the amendment and restatement of the Company’s Amended and Restated Bylaws (as so amended and restated, the “Bylaws”) to, among other things:","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-24-003356","anchor_url":"https://secwatch.observer/filing/0001193125-24-003356#claim-d011fdc10748f4b98e2327e3630754bcde739a0c","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1020214/000119312524003356/0001193125-24-003356-index.htm"},{"fact_type":"material_agreement","fact_key":"4d282d8cd9a5e7a58b52c109b078183f6a3bdda9","cik":1020214,"ticker":"CERS","company_name":"CERUS CORP","filed_at":"2024-01-05T23:59:59+00:00","payload":{"action":"amendment","agreement_name":"Term Loan Amendment","agreement_type":"credit_facility","counterparty":"MidCap Financial Trust","effective_date":"2024-01-05","item_codes_triggered":["1.01"],"value_text":null},"claim":"CERUS CORP amended Term Loan Amendment with MidCap Financial Trust (effective 2024-01-05).","evidence_excerpt":"On January 5, 2024, Cerus Corporation (the \"Company\") entered into a second amendment (the \"Term Loan Amendment\") to that certain Amended and Restated Credit, Security and Guaranty Agreement (Term Loan) dated as of March 31, 2023 by and among the Company, the lenders party thereto from time to time and MidCap Financial Trust, as agent and a lender.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001193125-24-003356","anchor_url":"https://secwatch.observer/filing/0001193125-24-003356#claim-4d282d8cd9a5e7a58b52c109b078183f6a3bdda9","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1020214/000119312524003356/0001193125-24-003356-index.htm"},{"fact_type":"earnings_release","fact_key":"1ec704cb4aef4ab816a225bbe89fb3be5d333eba","cik":1020214,"ticker":"CERS","company_name":"CERUS CORP","filed_at":"2023-11-02T23:59:59+00:00","payload":{"eps_text":"$0.04 per basic and diluted share","guidance_signal":"lowered","item_codes_triggered":["2.02"],"net_income_text":"$7.3 million","period_text":"third quarter ended September 30, 2023","report_date":"2023-11-02","result_type":"reported_results","revenue_text":"$47.3 million"},"claim":"CERUS CORP reported third quarter ended September 30, 2023 results: revenue $47.3 million, net income $7.3 million, EPS $0.04 per basic and diluted share. Guidance lowered.","evidence_excerpt":"Cerus Corporation (Nasdaq: CERS) today announced financial results for the third quarter ended September 30, 2023. Recent highlights include: • Third quarter 2023 total revenue of $47.3 million was comprised of total product revenue of $39.8 million and government contract revenue of $7.5 million. • Completed Phase 3 ReCePI study enrollment in cardiovascular surgery patients, with top-line data readout on track for Q1 2024. • Attended first in-person AABB Annual Meeting since 2019, where presentations from transfusion medicine leaders highlighted the growing experience with the benefits of INTERCEPT-treated products, including INTERCEPT platelets and INTERCEPT Fibrinogen Complex (IFC). • Cash, cash equivalents, and short-term investments were $79.0 million at September 30, 2023. • Reaffirming commitment to achieve non-GAAP adjusted EBITDA breakeven in the fourth quarter of 2023. “We continued to make progress on multiple fronts in the third quarter,” said William “Obi” Greenman, Cerus’","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0000950170-23-058154","anchor_url":"https://secwatch.observer/filing/0000950170-23-058154#claim-1ec704cb4aef4ab816a225bbe89fb3be5d333eba","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1020214/000095017023058154/0000950170-23-058154-index.htm"},{"fact_type":"earnings_release","fact_key":"2fdf464bea555935d8ea2bbdfe56d8ecacae6bff","cik":1020214,"ticker":"CERS","company_name":"CERUS CORP","filed_at":"2023-08-02T23:59:59+00:00","payload":{"eps_text":"$0.07 per basic and diluted share","guidance_signal":"lowered","item_codes_triggered":["2.02"],"net_income_text":"$13.3 million","period_text":"second quarter ended June 30, 2023","report_date":"2023-08-02","result_type":"reported_results","revenue_text":"$47.7 million"},"claim":"CERUS CORP reported second quarter ended June 30, 2023 results: revenue $47.7 million, net income $13.3 million, EPS $0.07 per basic and diluted share. Guidance lowered.","evidence_excerpt":"Cerus Corporation (Nasdaq: CERS) today announced financial results for the second quarter ended June 30, 2023. Recent highlights include: • Second quarter 2023 total revenue of $47.7 million","confidence":0.85,"filing_url":"https://secwatch.observer/filing/0000950170-23-037123","anchor_url":"https://secwatch.observer/filing/0000950170-23-037123#claim-2fdf464bea555935d8ea2bbdfe56d8ecacae6bff","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1020214/000095017023037123/0000950170-23-037123-index.htm"},{"fact_type":"shareholder_vote","fact_key":"bdbcbae9703a45a3cda711e694dc806eac43dc18","cik":1020214,"ticker":"CERS","company_name":"CERUS CORP","filed_at":"2023-06-12T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2023-06-07","outcome":"passed","proposal_text":"Ratification of Ernst & Young LLP as independent registered public accounting firm for fiscal year ending December 31, 2023","proposal_type":"auditor_ratification","results":[{"broker_non_votes":null,"subject":null,"votes_abstain":"313,896","votes_against":"2,708,212","votes_for":"147,337,044","votes_withheld":null}]},"claim":"CERUS CORP shareholders approved Ratification of Ernst & Young LLP as independent registered public accounting firm for fiscal year ending December 31, 2023 at the 2023-06-07 meeting.","evidence_excerpt":"For Against Abstain 147,337,044 2,708,212 313,896","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0000950170-23-027377","anchor_url":"https://secwatch.observer/filing/0000950170-23-027377#claim-bdbcbae9703a45a3cda711e694dc806eac43dc18","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1020214/000095017023027377/0000950170-23-027377-index.htm"},{"fact_type":"shareholder_vote","fact_key":"b65b01783b2e7e048a42b11b12b2f68397e1123b","cik":1020214,"ticker":"CERS","company_name":"CERUS CORP","filed_at":"2023-06-12T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2023-06-07","outcome":"passed","proposal_text":"Advisory approval of the compensation of the Company's named executive officers","proposal_type":"say_on_pay","results":[{"broker_non_votes":"32,590,544","subject":null,"votes_abstain":"310,834","votes_against":"13,411,996","votes_for":"104,045,778","votes_withheld":null}]},"claim":"CERUS CORP shareholders approved Advisory approval of the compensation of the Company's named executive officers at the 2023-06-07 meeting.","evidence_excerpt":"For Against Abstain Broker Non-Votes 104,045,778 13,411,996 310,834 32,590,544","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0000950170-23-027377","anchor_url":"https://secwatch.observer/filing/0000950170-23-027377#claim-b65b01783b2e7e048a42b11b12b2f68397e1123b","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1020214/000095017023027377/0000950170-23-027377-index.htm"},{"fact_type":"shareholder_vote","fact_key":"81ef3385d26feb8bbe903790ccf122e26cec3adc","cik":1020214,"ticker":"CERS","company_name":"CERUS CORP","filed_at":"2023-06-12T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2023-06-07","outcome":"passed","proposal_text":"Approval of amendment and restatement of the Company's Amended and Restated 2008 Equity Incentive Plan to increase shares by 7,000,000","proposal_type":"equity_plan","results":[{"broker_non_votes":"32,590,544","subject":null,"votes_abstain":"95,755","votes_against":"51,205,777","votes_for":"66,467,076","votes_withheld":null}]},"claim":"CERUS CORP shareholders approved Approval of amendment and restatement of the Company's Amended and Restated 2008 Equity Incentive Plan to increase shares by 7,000,000 at the 2023-06-07 meeting.","evidence_excerpt":"For Against Abstain Broker Non-Votes 66,467,076 51,205,777 95,755 32,590,544","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0000950170-23-027377","anchor_url":"https://secwatch.observer/filing/0000950170-23-027377#claim-81ef3385d26feb8bbe903790ccf122e26cec3adc","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1020214/000095017023027377/0000950170-23-027377-index.htm"},{"fact_type":"shareholder_vote","fact_key":"d99d75f586ca6cbe923782059d0ba224a3dee0af","cik":1020214,"ticker":"CERS","company_name":"CERUS CORP","filed_at":"2023-06-12T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2023-06-07","outcome":"passed","proposal_text":"Election of each of the three nominees to the Board of Directors to serve until the 2026 Annual Meeting","proposal_type":"director_election","results":[{"broker_non_votes":"32,590,544","subject":"William M. Greenman","votes_abstain":null,"votes_against":null,"votes_for":"107,784,791","votes_withheld":"9,983,817"},{"broker_non_votes":"32,590,544","subject":"Ann Lucena","votes_abstain":null,"votes_against":null,"votes_for":"114,400,723","votes_withheld":"3,367,885"},{"broker_non_votes":"32,590,544","subject":"Timothy L. Moore","votes_abstain":null,"votes_against":null,"votes_for":"101,673,607","votes_withheld":"16,095,001"}]},"claim":"CERUS CORP shareholders approved Election of each of the three nominees to the Board of Directors to serve until the 2026 Annual Meeting at the 2023-06-07 meeting.","evidence_excerpt":"William M. Greenman 107,784,791 9,983,817 32,590,544 Ann Lucena 114,400,723 3,367,885 32,590,544 Timothy L. Moore 101,673,607 16,095,001 32,590,544","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0000950170-23-027377","anchor_url":"https://secwatch.observer/filing/0000950170-23-027377#claim-d99d75f586ca6cbe923782059d0ba224a3dee0af","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1020214/000095017023027377/0000950170-23-027377-index.htm"},{"fact_type":"earnings_release","fact_key":"7cc442117760b2edfb9869e60897da84ff04ac9b","cik":1020214,"ticker":"CERS","company_name":"CERUS CORP","filed_at":"2023-05-04T23:59:59+00:00","payload":{"eps_text":null,"guidance_signal":"reaffirmed","item_codes_triggered":["2.02"],"net_income_text":null,"period_text":"first quarter ended March 31, 2023","report_date":"2023-05-04","result_type":"reported_results","revenue_text":"$38.5 million"},"claim":"CERUS CORP reported first quarter ended March 31, 2023 results: revenue $38.5 million. Guidance reaffirmed.","evidence_excerpt":"Cerus Corporation (Nasdaq: CERS) today announced financial results for the first quarter ended March 31, 2023. Recent highlights include: • First quarter 2023 total revenue of $38.5 million","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0000950170-23-017869","anchor_url":"https://secwatch.observer/filing/0000950170-23-017869#claim-7cc442117760b2edfb9869e60897da84ff04ac9b","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1020214/000095017023017869/0000950170-23-017869-index.htm"},{"fact_type":"debt_financing","fact_key":"196f641c4365337bfe9dbd6a2a6df8b2847a91d4","cik":1020214,"ticker":"CERS","company_name":"CERUS CORP","filed_at":"2023-04-05T23:59:59+00:00","payload":{"counterparty":"MidCap Funding IV Trust, as agent and a lender","effective_date":"2023-03-31","event":"incurrence","instrument_type":"revolving_credit","interest_rate_text":"Term SOFR rate (subject to a floor of 1.00%) plus 3.75%","item_codes_triggered":["2.03"],"maturity_text":"March 1, 2028","principal_text":"up to $20.0 million"},"claim":"CERUS CORP incurred revolving credit of up to $20.0 million with MidCap Funding IV Trust, as agent and a lender at Term SOFR rate (subject to a floor of 1.00%) plus 3.75% maturing March 1, 2028.","evidence_excerpt":"Exit Fee in connection with any prepayment. The Revolving Loan Credit Agreement provides a secured revolving credit facility in an initial aggregate principal amount of up to $20.0 million. The Company may request an increase in the total commitments under the Revolving Loan Credit Agreement by up to an additional $15.0 million, subject to agent and lender approval","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-23-092216","anchor_url":"https://secwatch.observer/filing/0001193125-23-092216#claim-196f641c4365337bfe9dbd6a2a6df8b2847a91d4","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1020214/000119312523092216/0001193125-23-092216-index.htm"},{"fact_type":"debt_financing","fact_key":"845ea9257930bd21c50aa8aa1a176fd83a85e343","cik":1020214,"ticker":"CERS","company_name":"CERUS CORP","filed_at":"2023-04-05T23:59:59+00:00","payload":{"counterparty":"MidCap Financial Trust, as agent and a lender","effective_date":"2023-03-31","event":"incurrence","instrument_type":"term_loan","interest_rate_text":"Term SOFR rate (subject to a floor of 1.00%) plus 6.50%","item_codes_triggered":["2.03"],"maturity_text":null,"principal_text":"up to $75.0 million"},"claim":"CERUS CORP incurred term loan of up to $75.0 million with MidCap Financial Trust, as agent and a lender at Term SOFR rate (subject to a floor of 1.00%) plus 6.50%.","evidence_excerpt":"2019, as amended (the “Existing Revolving Loan Credit Agreement”). The Term Loan Credit Agreement provides a secured term loan facility in an aggregate principal amount of up to $75.0 million. The Company borrowed the first advance of $40.0 million (“Tranche 1”) and the second advance of $15.0 million (“Tranche 2”) on the Closing Date to refinance the term loans under","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-23-092216","anchor_url":"https://secwatch.observer/filing/0001193125-23-092216#claim-845ea9257930bd21c50aa8aa1a176fd83a85e343","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1020214/000119312523092216/0001193125-23-092216-index.htm"},{"fact_type":"material_agreement","fact_key":"eca3ab4026be6d11dfdf46d88228e12a551852ed","cik":1020214,"ticker":"CERS","company_name":"CERUS CORP","filed_at":"2023-04-05T23:59:59+00:00","payload":{"action":"amendment","agreement_name":"Amended and Restated Credit, Security and Guaranty Agreement (Revolving Loan)","agreement_type":"credit_facility","counterparty":"MidCap Funding IV Trust, as agent and a lender","effective_date":"2023-03-31","item_codes_triggered":["1.01"],"value_text":"up to $20.0 million"},"claim":"CERUS CORP amended Amended and Restated Credit, Security and Guaranty Agreement (Revolving Loan) with MidCap Funding IV Trust, as agent and a lender valued at up to $20.0 million (effective 2023-03-31).","evidence_excerpt":"and (ii) an Amended and Restated Credit, Security and Guaranty Agreement (Revolving Loan) (the “Revolving Loan Credit Agreement,” and together with the Term Loan Credit Agreement, the “Credit Agreements”), by and among the Company, the lenders party thereto from time to time and MidCap Funding IV Trust, as agent and a lender, which amended and restated the Company’s existing Credit, Security and Guaranty Agreement (Revolving Loan), dated as of March 29, 2019, as amended (the “Existing Revolving Loan Credit Agreement”)","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-23-092216","anchor_url":"https://secwatch.observer/filing/0001193125-23-092216#claim-eca3ab4026be6d11dfdf46d88228e12a551852ed","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1020214/000119312523092216/0001193125-23-092216-index.htm"},{"fact_type":"material_agreement","fact_key":"74aa07b7485183a3b1bfa6140f3f02a4b7eac906","cik":1020214,"ticker":"CERS","company_name":"CERUS CORP","filed_at":"2023-04-05T23:59:59+00:00","payload":{"action":"amendment","agreement_name":"Amended and Restated Credit, Security and Guaranty Agreement (Term Loan)","agreement_type":"credit_facility","counterparty":"MidCap Financial Trust, as agent and a lender","effective_date":"2023-03-31","item_codes_triggered":["1.01"],"value_text":"up to $75.0 million"},"claim":"CERUS CORP amended Amended and Restated Credit, Security and Guaranty Agreement (Term Loan) with MidCap Financial Trust, as agent and a lender valued at up to $75.0 million (effective 2023-03-31).","evidence_excerpt":"On March 31, 2023, (the “Closing Date”), Cerus Corporation (the “Company”) entered into (i) an Amended and Restated Credit, Security and Guaranty Agreement (Term Loan) (the “Term Loan Credit Agreement”), by and among the Company, the lenders party thereto from time to time and MidCap Financial Trust, as agent and a lender, which amended and restated the Company’s existing Credit, Security and Guaranty Agreement (Term Loan), dated as of March 29, 2019, as amended (the “Existing Term Loan Credit Agreement”)","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-23-092216","anchor_url":"https://secwatch.observer/filing/0001193125-23-092216#claim-74aa07b7485183a3b1bfa6140f3f02a4b7eac906","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1020214/000119312523092216/0001193125-23-092216-index.htm"},{"fact_type":"earnings_release","fact_key":"c49aa51f8ed73daffd8410f8b618b25a0f883ea6","cik":1020214,"ticker":"CERS","company_name":"CERUS CORP","filed_at":"2023-02-28T23:59:59+00:00","payload":{"eps_text":"$0.08 per basic and diluted share","guidance_signal":"reaffirmed","item_codes_triggered":["2.02"],"net_income_text":"$13.6 million","period_text":"the fourth quarter ended December 31, 2022","report_date":"2023-02-28","result_type":"reported_results","revenue_text":"$44.0 million"},"claim":"CERUS CORP reported the fourth quarter ended December 31, 2022 results: revenue $44.0 million, net income $13.6 million, EPS $0.08 per basic and diluted share. Guidance reaffirmed.","evidence_excerpt":"Exhibit 99.1 Cerus Corporation Announces Record Fourth Quarter and Full-Year 2022 Financial Results Strong Revenue Growth Driven by Sales in North America Product Revenue of $44.0 Million Grew 10% YoY in the Fourth Quarter Reiterating Full-Year 2023 Product Revenue Guidance Range of $165-170 Million CONCORD, CA, February 28, 2023 - Cerus Corporation (Nasdaq: CERS)","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-23-053823","anchor_url":"https://secwatch.observer/filing/0001193125-23-053823#claim-c49aa51f8ed73daffd8410f8b618b25a0f883ea6","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1020214/000119312523053823/0001193125-23-053823-index.htm"},{"fact_type":"earnings_release","fact_key":"a32defc92df52093e48ff42412d8da055cdd6ecc","cik":1020214,"ticker":"CERS","company_name":"CERUS CORP","filed_at":"2023-01-09T23:59:59+00:00","payload":{"eps_text":null,"guidance_signal":"initiated","item_codes_triggered":["2.02"],"net_income_text":null,"period_text":"the fourth quarter and fiscal year ended December 31, 2022","report_date":"2023-01-09","result_type":"preliminary_results","revenue_text":"$44.0 million"},"claim":"CERUS CORP reported the fourth quarter and fiscal year ended December 31, 2022 results: revenue $44.0 million. Guidance initiated.","evidence_excerpt":"Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2022 Product Revenue and Provides Business Update Preliminary Fourth Quarter and Full-Year 2022 Product Revenues of $44.0 million and $162.0 million reflecting year-over-year growth of 10% and 24%, respectively","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001193125-23-004227","anchor_url":"https://secwatch.observer/filing/0001193125-23-004227#claim-a32defc92df52093e48ff42412d8da055cdd6ecc","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1020214/000119312523004227/0001193125-23-004227-index.htm"},{"fact_type":"earnings_release","fact_key":"b20ee8e73fe5d1e72af09d7dc800e1c90cda5ff2","cik":1020214,"ticker":"CERS","company_name":"CERUS CORP","filed_at":"2022-11-03T23:59:59+00:00","payload":{"eps_text":"$0.05 per basic and diluted share","guidance_signal":"reaffirmed","item_codes_triggered":["2.02"],"net_income_text":"$8.5 million","period_text":"third quarter ended September 30, 2022","report_date":"2022-11-03","result_type":"reported_results","revenue_text":"$46.3 million"},"claim":"CERUS CORP reported third quarter ended September 30, 2022 results: revenue $46.3 million, net income $8.5 million, EPS $0.05 per basic and diluted share. Guidance reaffirmed.","evidence_excerpt":"set forth by specific reference in such filing. \n\n--- EX-99.1 (EX-99.1) ---\n\nEX-99.1 Exhibit 99.1 Cerus Corporation Announces Third Quarter Financial Results Total Revenue of $46.3 Million Grew 10% YoY in the Third Quarter Product Revenue of $39.6 Million Grew 10% YoY in the Third Quarter despite 6% FX headwind CONCORD, CA, November 3, 2022 - Cerus Corporation","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001193125-22-276881","anchor_url":"https://secwatch.observer/filing/0001193125-22-276881#claim-b20ee8e73fe5d1e72af09d7dc800e1c90cda5ff2","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1020214/000119312522276881/0001193125-22-276881-index.htm"},{"fact_type":"executive_change","fact_key":"7ebec1bb5b","cik":1020214,"ticker":"CERS","company_name":"CERUS CORP","filed_at":"2022-07-05T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2022-07-01","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Hua Shan was appointed as Director at CERUS CORP.","evidence_excerpt":"the Board extended an offer to join the Board to Hua Shan, MD, PhD, and on June 30, 2022, Dr. Shan accepted such offer to join the Board, effective July 1, 2022.","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0001193125-22-187995","anchor_url":"https://secwatch.observer/filing/0001193125-22-187995#claim-7ebec1bb5b","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1020214/000119312522187995/0001193125-22-187995-index.htm"}]}